These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 88254)

  • 41. Immunohistochemical study of IOT-10 natural killer cells in brain metastases.
    Vaquero J; Coca S; Escandón J; Magallón R; Martínez R
    Acta Neurochir (Wien); 1990; 104(1-2):17-20. PubMed ID: 2166994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunoglobulins and complement components levels in patients with lung cancer.
    Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J
    Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunocytology of cancer.
    Davidsohn I; Ni LY
    Acta Cytol; 1970 May; 14(5):276-82. PubMed ID: 4935158
    [No Abstract]   [Full Text] [Related]  

  • 44. Extraction and preliminary characterization of tumor antigens in human bronchogenic adenocarcinoma and squamous cell carcinoma.
    Yamada T; Iwa T; Kurata Y; Okada S
    Eur J Cancer (1965); 1980 Jun; 16(6):781-92. PubMed ID: 6773777
    [No Abstract]   [Full Text] [Related]  

  • 45. The immune response at the tumor site in lung carcinoma.
    Ioachim HL; Dorsett BH; Paluch E
    Cancer; 1976 Dec; 38(6):2296-309. PubMed ID: 187316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Using two monoclonal antibodies to detect lung carcinoma associated antigen in the sera of patients with lung cancer by BA-ELISA].
    Xue W; Hou J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Feb; 13(1):63-7. PubMed ID: 1652380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ca 19-9 and Ca 50 in the diagnosis of bronchial carcinoma: comparison with CEA].
    Pecchio F; Rapellino M; Oliaro A; Moscato D; Adamo R; Albertino B; Lo Faso C; Faga C; Borasio P
    Minerva Med; 1988 Mar; 79(3):183-6. PubMed ID: 2834670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An assessment of MAC 387 antibody as a diagnostically useful marker of L1 epithelial antigen expression by lung tumours.
    Fitzmaurice RJ; Butterworth DM; Benbow EW
    J Pathol; 1991 Nov; 165(3):269. PubMed ID: 1762034
    [No Abstract]   [Full Text] [Related]  

  • 49. Preferential expression of immunoreactive fucosylceramide in adenocarcinoma of the lung.
    Yamada H; Ishihara H; Kitagawa H; Kawabata Y; Itoyama S; Sugawara I
    Cancer Res; 1992 Aug; 52(16):4408-12. PubMed ID: 1322788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of antigens associated with lung carcinoma in sera by monoclonal antibodies WLA-2C4 and CL-3.
    Wang DS; Huang W; Yuan M; Shi JQ
    Chin Med J (Engl); 1992 Nov; 105(11):905-8. PubMed ID: 1304459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [McAb LC-1 against human lung cancer].
    Ge XR; Wang J; Lin SJ; Yu NX; Che YF; Gu Y
    Shi Yan Sheng Wu Xue Bao; 1989 Sep; 22(3):359-65. PubMed ID: 2555985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunologic aspects of small cell carcinoma.
    Forbes JT; Greco FA; Oldham RK
    Semin Oncol; 1978 Sep; 5(3):263-71. PubMed ID: 80823
    [No Abstract]   [Full Text] [Related]  

  • 53. Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227.
    Shitara K; Hanai N; Yoshida H
    Anticancer Res; 1993; 13(3):579-86. PubMed ID: 7686360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen].
    Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histocompatibility antigen expression in pulmonary carcinomas as indication of differentiation and of special subtypes.
    Dämmrich J; Müller-Hermelink HK; Mattner A; Buchwald J; Ziffer S
    Cancer; 1990 May; 65(9):1942-54. PubMed ID: 2164874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Significance of CEA in sputum in examination of lung cancer].
    Muraoka H; Katoh H; Moriya H; Kimura K; Higuchi Y
    Rinsho Hoshasen; 1985 Mar; 30(3):379-84. PubMed ID: 2991629
    [No Abstract]   [Full Text] [Related]  

  • 57. [Generation and identify of a panel of monoclonal antibodies against carcinoma of the lung].
    Liu LA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Oct; 10(5):352-6. PubMed ID: 2978255
    [No Abstract]   [Full Text] [Related]  

  • 58. [Diagnostic value of the assay of carbohydrate antigen 19-9 in patients with primary bronchial cancer].
    Letanche G; Ogier I; Weynants P; Hartmann DJ; Ville G; Cordier JF; Brune J
    Rev Pneumol Clin; 1985; 41(5):314-6. PubMed ID: 3006207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CEA-like antigens in different histologic types of human lung carcinoma.
    Harłozińska A; Albert W; Rogalski E; Richter R; Albert Z
    Neoplasma; 1979; 26(2):145-56. PubMed ID: 89630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.